All privileges reserved. Neither of the parties endorse or suggest any commercial products, services, or equipment.. BMS Licenses Peptidream Technology, Extends Collaboration PeptiDream said today it decided to permit nonexclusively its Peptide Discovery System Program technology to Bristol-Myers Squibb , aswell as to another expansion of a related collaboration-;a nearly three-year-aged macrocyclic peptide medication discovery alliance-;with the pharma giant. ‘The PDPS technology permit was predicated on the successes accomplished during the first 3 years of our discovery collaboration with Bristol-Myers Squibb,’ PeptiDream CEO Kiichi Kubota stated in a declaration. That collaboration premiered Oct. 15, 2010, extended last Oct then.

Specialists believe the cervical disc implant allows patients to keep normal neck motion and help avoid further surgery due to the degeneration of adjacent segments. The green light entails Medtronic agreeing to conduct a seven-year post-approval research to judge the long-term basic safety and effectiveness of the cervical disc implant.. Cervical disc to treat degenerative disease gets FDA green light The Food and Medication Administration in the U.S. Has provided authorization for a cervical disk implant to take care of patients with degenerative disc disease. The cervical disc implant ‘Prestige’ is produced by Medtronic and is designed to be utilized in the throat to treat degenerative disc disease. The disc offers an alternative treatment to the original spinal fusion treatment and the possibility of movement as well as providing another choice for treatment.All privileges reserved. Neither of the parties endorse or suggest any commercial products, services, or equipment.. BMS Licenses Peptidream Technology, Extends Collaboration PeptiDream said today it decided to permit nonexclusively its Peptide Discovery System Program technology to Bristol-Myers Squibb , aswell as to another expansion of a related collaboration-;a nearly three-year-aged macrocyclic peptide medication discovery alliance-;with the pharma giant. ‘The PDPS technology permit was predicated on the successes accomplished during the first 3 years of our discovery collaboration with Bristol-Myers Squibb,’ PeptiDream CEO Kiichi Kubota stated in a declaration. That collaboration premiered Oct. 15, 2010, extended last Oct then.